What to focus on in a global public health crisis? Saving lives or chasing profit? Different countries and interest groups have given different answers. One latest example has happened in China. Pfizer's COVID treatment drug, Paxlovid, did not make it into China's national medical insurance program, as the...More

Beijing plans to distribute Pfizer's COVID-19 treatment drug Paxlovid to community health centers in a bid to help treatment of key populations as the city's peak caseload approaches, the Global Times learned from an online training session for doctors and nursing staff about how to direct patients to...More